Home » Healthcare » Pharmaceuticals » Anti-Infective Drugs Market

Anti-Infective Drugs Market By Type (Anti-Bacterials, Anti-Virals, Anti-Fungals, Others), By Range (Broad Spectrum, Narrow Spectrum) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Summary
Table Of Content

Industry Outlook

The growing prevalence of infections such as influenza, the ebola virus, and HIV has brought significant changes in the outlook of the general population about infections and their management, and consequently, in the consumption of anti-infective agents. Furthermore, collaborative efforts from organizations such as the WHO and health ministries to raise awareness and improve treatment outcomes for communicable diseases are important factors influencing the growth of the anti-infectives market. Additionally, the introduction of novel therapeutic agents, extensive R&D initiatives, and swift commercialization of pipeline products will also contribute to market growth. The global anti-infective drugs market is expected to reach US$ 168,628.1 Mn by 2026, expanding at a CAGR of 4.3/5 from 2018 to 2026.

Market Synopsis

Higher Prevalence of Bacterial Infections to Contribute to the Dominance of Antibacterial Drugs

The antibacterial segment is the largest revenue contributor to the global anti-infective drugs market. High incidences of bacterial infections, high prescription rates, and greater adoption of broad-spectrum antibiotics mainly drive the dominance of this segment. Antifungals such as azoles, polyenes, and echinocandins are in high demand due to their proven ability to treat systemic fungal infections. Furthermore, the anti-viral drugs segment will register the fastest growth during the forecast period from 2018 to 2026 due to the swift introduction of novel drugs and the ever-growing prevalence of viral infections worldwide that demand prolonged administration of anti-virals. The discovery of newer forms of viral agents and growing collaborations between governments, research organizations, and drug manufacturers also support the swift growth of this segment.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Broad-Spectrum Anti-Infectives to Spearhead the Global Market

The growing incidence of drug-resistant bacterial infections is a prime aspect governing the demand for broad-spectrum anti-infectives. Broad-spectrum antibiotics act on both gram-positive and gram-negative pathogens, therefore expanding the range of treatment. This feature of broad-spectrum antibiotics makes them ideal in cases of drug resistance and infection with multiple bacteria. On the other hand, the demand for narrow-spectrum anti-infective drugs will be steady and limited to such infections where the identity of the causative pathogen is known.

High Burden of Hepatitis, HIV, and Tuberculosis to Direct the Market’s Growth

The Global Burden of Disease report released in 2017 stated that the number of deaths caused by viral hepatitis had surpassed all chronic infections, including HIV and AIDS, tuberculosis, and malaria. The study reported that in 2016, the total deaths caused by hepatitis, including cirrhosis, hepatitis A, B, C, D, and E, and liver cancer accounted for 1.34 million, which exceeded tuberculosis at 1.2 million and HIV/AIDS and malaria at 1 million and 719,000 deaths, respectively. The increasing incidence and reporting of hepatitis with the help of advanced diagnostic techniques mainly contribute to the growing demand for anti-infectives for the treatment of these diseases.

The Asia Pacific region is poised to become a lucrative market for anti-infectives.

The market for anti-infective drugs is dominated by North America in terms of revenue and volume consumption. The prominence of the North American market is driven by the presence of sophisticated and well-organized healthcare infrastructure, as well as the increased adoption of advanced and novel medications. Because of its large geriatric population and the rapid introduction and adoption of novel therapeutics in the region, the United States is the leading stakeholder in the global market. Favorable reimbursements also play a critical role in assisting the dominance of the U.S. market. Asia Pacific, on the grounds of an escalating patient pool and rapid improvements in the healthcare system, will be the fastest-progressing regional market during the forecast period.

Periods of History and Forecast

2016 : Historic year.

2017: Base Year

2018–2026: Forecast Period

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The anti-infective drugs market report provides a quantitative assessment of the industry terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on drugs, type of infection, range of action, and geography.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

By Drugs (2016–2026; US$ Mn)

Antibacterial
Anti-virals
Anti-fungals
Others (Antihelmethics, Antiprotozoals, etc.)

By Range (2016–2026; US$ Mn)

Broad Spectrum
Narrow Spectrum

By Range (2016–2026; US$ Mn)

Hepatitis B
Hepatitis C
HIV
Malaria
Tuberculosis
Urinary Tract Infection
Others (meningitis, pneumonia, sexually transmitted diseases, etc.)

Geography Segment (2016–2026; US$ Mn)

North America

- U.S.
- Canada
Europe
- U.K.
- Germany
- Rest of Europe
Asia Pacific (APAC)
- China
- Japan
- India
- Rest of APAC
Latin America (LATAM)
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa (MEA)
- GCC
- Rest of the Middle East and Africa

The ongoing dynamics in the global anti-infective drugs market are scrutinized in this study to understand the progress of this market. The market dynamics are assessed in terms of drivers, challenges, and opportunities, thus giving insights into the positive aspects and pain points prevalent in the market. Prominent players in this market are also analyzed in terms of business overview, financial status, product portfolio, and key developments. The major companies engaged in the global anti-infective drugs market include Abbott Laboratories, Inc., Allergen plc, Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Bristol-Myers Squibb Co., Boehringer Ingelheim, F. Hoffman-La Roche Ltd., Gilead Sciences, GlaxoSmithKline Plc, Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Sanofi-Aventis SA, and Novartis AG.

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Anti-infective Drugs Market Portraiture
2.2. Global Anti-infective Drugs Market, by Type, 2017 (US$ Mn)
2.3. Global Anti-infective Drugs Market, by Range, 2017 (US$ Mn)
2.4. Global Anti-infective Drugs Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Anti-infective Drugs Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Anti-infective Drugs Market, by Key Players, 2017

Chapter 4. Global Anti-infective Drugs Market, by Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Anti-bacterials
4.3. Anti-virals
4.4. Anti-fungals
4.5. Others (Antihelmethics, Antiprotozoals, etc.)

Chapter 5. Global Anti-infective Drugs Market, by Range, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Broad Spectrum
5.3. Narrow Spectrum

Chapter 6. Global Anti-infective Drugs Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.1.1. North America Anti-infective Drugs Market, 2016-2026 (US$ Mn)
6.1.2. North America Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
6.1.3. North America Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
6.1.4. North America Anti-infective Drugs Market, by Country, 2016 – 2026 (US$ Mn)
6.1.4.1. U.S.
6.1.4.2. Canada
6.2. Europe Anti-infective Drugs Market, 2016 – 2026 (US$ Mn)
6.2.1. Europe Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. Europe Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
6.2.3. Europe Anti-infective Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Anti-infective Drugs Market, 2016 – 2026 (US$ Mn)
6.3.1. Asia Pacific Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Asia Pacific Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
6.3.3. Asia Pacific Anti-infective Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America Anti-infective Drugs Market, 2016 – 2026 (US$ Mn)
6.4.1. Latin America Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Latin America Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
6.4.3. Latin America Anti-infective Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Anti-infective Drugs Market, 2016 – 2026 (US$ Mn)
6.5.1. Middle East & Africa Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Middle East & Africa Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
6.5.3. Middle East & Africa Anti-infective Drugs Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Allergen plc
7.3. Astellas Pharma Inc.
7.4. AstraZeneca Plc
7.5. Bayer AG
7.6. Bristol-Myers Squibb Co.
7.7. Boehringer Ingelheim
7.8. F. Hoffman-La Roche Ltd.
7.9. Gilead Sciences
7.10. GlaxoSmithKline Plc
7.11. Johnson and Johnson
7.12. Merck & Co., Inc.
7.13. Pfizer, Inc.
7.14. Sanofi-Aventis SA
7.15. Novartis AG

List of Figures’

FIG 1. Anti-infective Drugs Market: Research Methodology
FIG 2. Anti-infective Drugs: Market Segmentation
FIG 3. Global Anti-infective Drugs Market, by Type, 2017 (US$ Mn)
FIG 4. Global Anti-infective Drugs Market, by Range, 2017 (US$ Mn)
FIG 5. Global Anti-infective Drugs Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Anti-infective Drugs Market, by Key Players, 2017
FIG 8. Global Anti-bacterial Drugs Market, 2016-2026(US$ Mn)
FIG 9. Global Anti-viral Drugs Market, 2016-2026 (US$ Mn)
FIG 10. Global Anti-fungal Drugs Market, 2016-2026 (US$ Mn)
FIG 11. Global Other Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 12. Global Broad Range Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 13. Global Narrow Range Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 14. U.S. Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 15. Canada Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 16. U.K. Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 17. Germany Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 18. Rest of Europe Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 19. China Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 20. Japan Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 21. India Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Asia Pacific Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 23. Brazil Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 24. Mexico Anti-infective Drugs
FIG 25. Market, 2016-2026 (US$ Mn)
FIG 26. Rest of Latin America Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 27. GCC Anti-infective Drugs Market, 2016-2026 (US$ Mn)
FIG 28. Rest of Middle East and Africa Anti-infective Drugs Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Anti-infective Drugs Market Portraiture
TABLE 2 Global Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
TABLE 4 Global Anti-infective Drugs Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn
TABLE 7 North America Anti-infective Drugs Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Anti-infective Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Anti-infective Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn
TABLE 16 Latin America Anti-infective Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Anti-infective Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Anti-infective Drugs Market, by Range, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa Anti-infective Drugs Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Allergen Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Astellas Pharma, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 AstraZeneca Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Bristol-Myers Squibb Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 F. Hoffman-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Gilead Sciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Johnson and Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Merck & Co., Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Pfizer, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Sanofi-Aventis SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions:

What is the size of Anti-Infective Drugs Market?

The market for Anti-Infective Drugs is expected to reach US$ XX Bn in 2026.

What is the Anti-Infective Drugs Market CAGR?

The Anti-Infective Drugs market is expected to see significant CAGR growth over the coming years,at XX%.

What is the Forecast period considered for Anti-Infective Drugs Market?

The report is forecasted from 2018-2026.

What is the base year considered for Anti-Infective Drugs Market?

The base year of this report is 2017.

Who are the major players in this Market?

Abbott Laboratories Inc.,Allergen plc,Astellas Pharma Inc.,AstraZeneca Plc,Bayer AG are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –